Design and synthesis of novel 2- substituted benzothiazole compounds as PTP1B inhibitors

Arun P. Chandrasekharappa, Sangamesh E. Badiger, Pramod K. Dubey, Sunil K. Panigrahi, Sekhar Reddy V V V Manukonda

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Protein tyrosine phosphatase 1B (PTP1B) is a well known drug target for the treatment of type 2 diabetes mellitus (T2DM). Diverse inhibitors have been reported in literature that inhibit PTP1B. We have reported 2-substituted benzoxazole class of In PTP1B inhibitors earlier. Present work describes 2-substituted benzothiazole compounds as PTP1B inhibitor as an extension of our previous study. Compound 23c, a disubstituted para-Bromobenzyl sulfonamide compound, exhibited moderate biochemical potency (Ki) of 1.4 μM. SAR on synthesized compounds was explained using molecular modeling study.

Original languageEnglish (US)
Pages (from-to)444-453
Number of pages10
JournalLetters in Drug Design and Discovery
Volume11
Issue number4
DOIs
StatePublished - 2014
Externally publishedYes

Fingerprint

Non-Receptor Type 1 Protein Tyrosine Phosphatase
Benzoxazoles
Sulfonamides
Type 2 Diabetes Mellitus
benzothiazole
Pharmaceutical Preparations

Keywords

  • Benzothiazoles
  • Disubstituted sulfonamides
  • Oxamic acids
  • PTP1B
  • PTyr mimetics
  • Type 2 Diabetes

ASJC Scopus subject areas

  • Drug Discovery
  • Molecular Medicine
  • Pharmaceutical Science

Cite this

Chandrasekharappa, A. P., Badiger, S. E., Dubey, P. K., Panigrahi, S. K., & Manukonda, S. R. V. V. V. (2014). Design and synthesis of novel 2- substituted benzothiazole compounds as PTP1B inhibitors. Letters in Drug Design and Discovery, 11(4), 444-453. https://doi.org/10.2174/15701808113106660076

Design and synthesis of novel 2- substituted benzothiazole compounds as PTP1B inhibitors. / Chandrasekharappa, Arun P.; Badiger, Sangamesh E.; Dubey, Pramod K.; Panigrahi, Sunil K.; Manukonda, Sekhar Reddy V V V.

In: Letters in Drug Design and Discovery, Vol. 11, No. 4, 2014, p. 444-453.

Research output: Contribution to journalArticle

Chandrasekharappa, AP, Badiger, SE, Dubey, PK, Panigrahi, SK & Manukonda, SRVVV 2014, 'Design and synthesis of novel 2- substituted benzothiazole compounds as PTP1B inhibitors', Letters in Drug Design and Discovery, vol. 11, no. 4, pp. 444-453. https://doi.org/10.2174/15701808113106660076
Chandrasekharappa, Arun P. ; Badiger, Sangamesh E. ; Dubey, Pramod K. ; Panigrahi, Sunil K. ; Manukonda, Sekhar Reddy V V V. / Design and synthesis of novel 2- substituted benzothiazole compounds as PTP1B inhibitors. In: Letters in Drug Design and Discovery. 2014 ; Vol. 11, No. 4. pp. 444-453.
@article{582363110693461b9e3893b4e7f342eb,
title = "Design and synthesis of novel 2- substituted benzothiazole compounds as PTP1B inhibitors",
abstract = "Protein tyrosine phosphatase 1B (PTP1B) is a well known drug target for the treatment of type 2 diabetes mellitus (T2DM). Diverse inhibitors have been reported in literature that inhibit PTP1B. We have reported 2-substituted benzoxazole class of In PTP1B inhibitors earlier. Present work describes 2-substituted benzothiazole compounds as PTP1B inhibitor as an extension of our previous study. Compound 23c, a disubstituted para-Bromobenzyl sulfonamide compound, exhibited moderate biochemical potency (Ki) of 1.4 μM. SAR on synthesized compounds was explained using molecular modeling study.",
keywords = "Benzothiazoles, Disubstituted sulfonamides, Oxamic acids, PTP1B, PTyr mimetics, Type 2 Diabetes",
author = "Chandrasekharappa, {Arun P.} and Badiger, {Sangamesh E.} and Dubey, {Pramod K.} and Panigrahi, {Sunil K.} and Manukonda, {Sekhar Reddy V V V}",
year = "2014",
doi = "10.2174/15701808113106660076",
language = "English (US)",
volume = "11",
pages = "444--453",
journal = "Letters in Drug Design and Discovery",
issn = "1570-1808",
publisher = "Bentham Science Publishers B.V.",
number = "4",

}

TY - JOUR

T1 - Design and synthesis of novel 2- substituted benzothiazole compounds as PTP1B inhibitors

AU - Chandrasekharappa, Arun P.

AU - Badiger, Sangamesh E.

AU - Dubey, Pramod K.

AU - Panigrahi, Sunil K.

AU - Manukonda, Sekhar Reddy V V V

PY - 2014

Y1 - 2014

N2 - Protein tyrosine phosphatase 1B (PTP1B) is a well known drug target for the treatment of type 2 diabetes mellitus (T2DM). Diverse inhibitors have been reported in literature that inhibit PTP1B. We have reported 2-substituted benzoxazole class of In PTP1B inhibitors earlier. Present work describes 2-substituted benzothiazole compounds as PTP1B inhibitor as an extension of our previous study. Compound 23c, a disubstituted para-Bromobenzyl sulfonamide compound, exhibited moderate biochemical potency (Ki) of 1.4 μM. SAR on synthesized compounds was explained using molecular modeling study.

AB - Protein tyrosine phosphatase 1B (PTP1B) is a well known drug target for the treatment of type 2 diabetes mellitus (T2DM). Diverse inhibitors have been reported in literature that inhibit PTP1B. We have reported 2-substituted benzoxazole class of In PTP1B inhibitors earlier. Present work describes 2-substituted benzothiazole compounds as PTP1B inhibitor as an extension of our previous study. Compound 23c, a disubstituted para-Bromobenzyl sulfonamide compound, exhibited moderate biochemical potency (Ki) of 1.4 μM. SAR on synthesized compounds was explained using molecular modeling study.

KW - Benzothiazoles

KW - Disubstituted sulfonamides

KW - Oxamic acids

KW - PTP1B

KW - PTyr mimetics

KW - Type 2 Diabetes

UR - http://www.scopus.com/inward/record.url?scp=84898756470&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84898756470&partnerID=8YFLogxK

U2 - 10.2174/15701808113106660076

DO - 10.2174/15701808113106660076

M3 - Article

AN - SCOPUS:84898756470

VL - 11

SP - 444

EP - 453

JO - Letters in Drug Design and Discovery

JF - Letters in Drug Design and Discovery

SN - 1570-1808

IS - 4

ER -